ArticleMolecular cancer2024

N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.

Diguang Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.